Mammalian Cell Fermentation Technology Market Analysis

Type (Chinese Hamster Ovary [CHO] Cell Fermentation, Human Embryonic Kidney [HEK] Cell Fermentation, Baby Hamster Kidney [BHK] Cell Fermentation, Murine Myeloma Cell Fermentation)

The Chinese hamster ovary (CHO) cell fermentation segment in the mammalian cell fermentation technology market is estimated to capture share of about 40% over the coming years. For many years, Chinese hamster ovary cells, or CHO cells, have been cultivated and modified for use in pharmaceutical biotechnology and molecular biology. Furthermore, this fermentation process is extensively utilized in manufacturing monoclonal antibodies and therapeutic proteins. Furthermore, therapeutics proteins are used to treat HIV. Therefore, with the growing prevalence of HIV the segment is growing. In 2022, there were about 39 million HIV-positive individuals in the world. Of them, 1.5 million were children under the age of fifteen, and 37.5 million were adults. Furthermore, 53% of the population was female. Additionally, the capacity of Chinese hamster ovary cells to generate proteins with complex glycosylations, or post-translational modifications (PTMs), that resemble those produced by humans, is the main advantage of using them as mammalian cell line expression platforms. Other common in vitro cell types, including E. coli, cannot produce recombinant proteins of this high quality.

End-Use (CMOs & CDMOs, Biopharmaceutical Companies, Academic & Research Institutes)

The CMOs & CDMOs segment in the mammalian cell fermentation technology market is set to capture the highest share of 50% during the forecast period. This is since smaller companies generate most of the innovation in the bioprocess industry yet lack the capacity, experienced personnel, and resources required for the commercialization of these products, CMOs and CDMOs are fast becoming the go-to option for makers of biotherapeutics. Hence, with the growing small companies in the field of biotherapeutic the segment is anticipated to rise.

Our in-depth analysis of the global mammalian cell fermentation technology market includes the following segments: